OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
This Quarter Return
-1.31%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
AUM
$58.3M
AUM Growth
+$58.3M
Cap. Flow
-$3.29M
Cap. Flow %
-5.64%
Top 10 Hldgs %
53.36%
Holding
75
New
1
Increased
16
Reduced
1
Closed
13
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GTHX
26
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$639K 0.95%
20,844
GWPH
27
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$633K 0.94%
3,674
EPZM
28
DELISTED
Epizyme, Inc
EPZM
$632K 0.94%
50,378
CRSP icon
29
CRISPR Therapeutics
CRSP
$4.71B
$622K 0.92%
13,214
ARNA
30
DELISTED
Arena Pharmaceuticals Inc
ARNA
$573K 0.85%
9,770
CELG
31
DELISTED
Celgene Corp
CELG
$520K 0.77%
5,625
-2,885
-34% -$267K
MGNX icon
32
MacroGenics
MGNX
$112M
$510K 0.75%
30,075
GBT
33
DELISTED
Global Blood Therapeutics, Inc.
GBT
$499K 0.74%
9,479
PCRX icon
34
Pacira BioSciences
PCRX
$1.2B
$489K 0.72%
11,250
BHVN
35
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$475K 0.7%
10,852
ICPT
36
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$467K 0.69%
5,872
+116
+2% +$9.23K
NTLA icon
37
Intellia Therapeutics
NTLA
$1.22B
$466K 0.69%
28,490
ZGNX
38
DELISTED
Zogenix, Inc.
ZGNX
$465K 0.69%
9,725
FOLD icon
39
Amicus Therapeutics
FOLD
$2.34B
$458K 0.68%
36,731
NKTR icon
40
Nektar Therapeutics
NKTR
$568M
$445K 0.66%
12,503
+2,198
+21% +$78.2K
DCPH
41
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$420K 0.62%
18,631
VKTX icon
42
Viking Therapeutics
VKTX
$3.04B
$402K 0.59%
48,485
MDGL icon
43
Madrigal Pharmaceuticals
MDGL
$9.76B
$374K 0.55%
3,570
FBIO icon
44
Fortress Biotech
FBIO
$76.8M
$351K 0.52%
234,030
ANAB icon
45
AnaptysBio
ANAB
$569M
$345K 0.51%
6,116
CKPT
46
DELISTED
Checkpoint Therapeutics
CKPT
$342K 0.51%
112,760
AMRN
47
Amarin Corp
AMRN
$311M
$323K 0.48%
16,641
TECH icon
48
Bio-Techne
TECH
$8.5B
$323K 0.48%
1,551
RARE icon
49
Ultragenyx Pharmaceutical
RARE
$2.89B
$322K 0.48%
5,064
ACAD icon
50
Acadia Pharmaceuticals
ACAD
$4.38B
$320K 0.47%
11,981